Loading…
Operates in Healthcare Services — Other healthcare services. Per the activity note to the FY2024 annual report, the company provides healthcare and laboratory services. Founded on 15 June 2012; provides other healthcare activities including laboratory services.
| Ratio | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross Margin | 69.7% | 65.4% | 63.7% | 41.6% | 56.6% | 94.1% |
| EBITDA Margin | -39.1% | -10.1% | 31.3% | -133.4% | -47.2% | 16.0% |
| EBITDAR | -268 | -59 | 567 | -525 | -172 | 78 |
| EBITDAR Margin | -35.1% | -6.2% | 35.0% | -119.8% | -39.1% | 27.9% |
| EBIT Margin | -50.8% | -19.7% | 25.5% | -156.6% | -69.8% | -4.4% |
| Net Profit Margin | -50.8% | -10.1% | 25.6% | -156.6% | -69.8% | -4.4% |
| Operating Expense % of Sales | 108.8% | 75.5% | 32.5% | 175.0% | 103.8% | 78.1% |
| Returns | ||||||
| Return on Assets (ROA) | -30.3% | -5.8% | 27.9% | -55.2% | -29.8% | -1.2% |
| Return on Equity (ROE) | -97.8% | -44.8% | 996.0% | N/A | N/A | N/A |
| ROIC [EBIT / Invested Capital] | -127.6% | -103.6% | N/A | N/A | N/A | N/A |
| Leverage & debt balances | ||||||
| Debt-to-Assets | 0.0% | 1.8% | 2.3% | 4.3% | 4.0% | 1.0% |
| Debt-to-Equity | 0.00x | 0.14x | 0.81x | -0.10x | -0.06x | -0.01x |
| Debt-to-EBITDA | N/A | N/A | 0.07x | N/A | N/A | 0.22x |
| Equity-to-Assets | 31.0% | 12.8% | 2.8% | -42.0% | -62.7% | -68.8% |
| Net Debt | -92 | -35 | -93 | -34 | -88 | -98 |
| Cash & Equivalents | 92 | 64 | 127 | 88 | 129 | 108 |
| Total Debt | N/A | 30 | 34 | 53 | 41 | 10 |
| Liquidity & working capital | ||||||
| Current Ratio | 0.43x | 0.69x | 0.39x | 0.47x | 0.47x | 0.38x |
| Quick Ratio | 0.11x | 0.14x | 0.39x | 0.47x | 0.47x | 0.38x |
| Cash Ratio | 0.10x | 0.04x | 0.07x | 0.07x | 0.10x | 0.08x |
| Total Current Assets | 381 | 983 | 696 | 567 | 629 | 516 |
| Total Current Liabilities | 883 | 1,433 | 1,774 | 1,213 | 1,344 | 1,372 |
| Inventory | 287 | 781 | N/A | N/A | N/A | N/A |
| Trade Receivables | 3 | 138 | 101 | 74 | 74 | 74 |
| Trade Payables | 883 | 1,403 | 1,174 | 1,213 | 1,344 | 1,372 |
| Net Working Capital | -501 | -451 | -1,078 | -645 | -715 | -856 |
| Net Working Capital % of Revenue | -65.8% | -47.3% | -66.6% | -147.3% | -162.0% | -306.2% |
| Trade Working Capital | -594 | -484 | -1,073 | -1,139 | -1,270 | -1,297 |
| Trade Working Capital % of Revenue | -77.9% | -50.8% | -66.3% | -259.8% | -287.9% | -464.2% |
| Change in Trade Working Capital | N/A | 109 | -588 | -66 | -131 | -28 |
| Turnover & efficiency | ||||||
| Inventory Turnover | 0.81x | 0.42x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 452.9 | 863.2 | N/A | N/A | N/A | N/A |
| Receivables Turnover | 295.11x | 6.91x | 16.07x | 5.91x | 5.95x | 3.77x |
| Days Sales Outstanding (DSO) | 1.2 | 52.8 | 22.7 | 61.8 | 61.3 | 96.9 |
| Payables Turnover | 0.26x | 0.24x | 0.50x | 0.21x | 0.14x | 0.01x |
| Days Payable Outstanding (DPO) | 1395.5 | 1551.3 | 729.7 | 1729.8 | 2564.1 | 30454.8 |
| Cash Conversion Cycle | -941.3 days | -635.3 days | -706.9 days | -1668.0 days | -2502.8 days | -30357.9 days |
| Asset Turnover | 0.60x | 0.57x | 1.09x | 0.35x | 0.43x | 0.28x |
| Cash flow & dividends | ||||||
| Operating Cash Flow | 82 | -28 | 63 | -39 | 41 | -21 |
| Free Cash Flow (OCF − Capex proxy) | 82 | -28 | 63 | -39 | 41 | -21 |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | 12.4% | N/A | N/A | -47.0% |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →